您的位置: 首页 > 农业专利 > 详情页

NOVEL SHRNA GENE THERAPY FOR TREATMENT OF ISCHEMIC HEART DISEASE
专利权人:
Mei Huang;Amato John Giaccia;Denise A. Chan;Joseph C. Wu
发明人:
Joseph C. Wu,Amato John Giaccia,Mei Huang,Denise A. Chan
申请号:
US12998075
公开号:
US20120004283A1
申请日:
2009.09.15
申请国别(地区):
US
年份:
2012
代理人:
摘要:
Short hairpin RNA (shRNA) interference therapy targeting hypoxia inducible factor—lot (HIF-1 α) prolyl-4-hydroxylase protein (HIF-PHD2) is used for treatment of myocardial ischemia. This treatment can be followed noninvasively by molecular imaging. Provided are compositions comprising novel vectors encoding shRNA targeting the HIF-1α and asparaginyl hydroxylase genes. The vectors encoding shRNA are also useful for the treatment of cardiac diseases, peripheral vascular diseases and decubitis ulcers.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充